STELLANTIS NV (STLAP.PA) Fundamental Analysis & Valuation

EPA:STLAP • NL00150001Q9

Current stock price

6.215 EUR
-0.42 (-6.4%)
Last:

This STLAP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. STLAP.PA Profitability Analysis

1.1 Basic Checks

  • STLAP had positive earnings in the past year.
  • In the past year STLAP has reported a negative cash flow from operations.
  • Of the past 5 years STLAP 4 years were profitable.
  • Of the past 5 years STLAP 4 years had a positive operating cash flow.
STLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFSTLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B -20B

1.2 Ratios

  • STLAP has a worse Return On Assets (-1.19%) than 70.97% of its industry peers.
  • Looking at the Return On Equity, with a value of -3.27%, STLAP is doing worse than 67.74% of the companies in the same industry.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)0.12%
ROA(5y)3.53%
ROE(3y)-4.1%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
STLAP.PA Yearly ROA, ROE, ROICSTLAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • STLAP's Gross Margin of 7.74% is on the low side compared to the rest of the industry. STLAP is outperformed by 74.19% of its industry peers.
  • In the last couple of years the Gross Margin of STLAP has declined.
  • STLAP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.41%
GM growth 5Y-43.81%
STLAP.PA Yearly Profit, Operating, Gross MarginsSTLAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. STLAP.PA Health Analysis

2.1 Basic Checks

  • STLAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, STLAP has more shares outstanding
  • The number of shares outstanding for STLAP has been increased compared to 5 years ago.
  • Compared to 1 year ago, STLAP has a worse debt to assets ratio.
STLAP.PA Yearly Shares OutstandingSTLAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
STLAP.PA Yearly Total Debt VS Total AssetsSTLAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B

2.2 Solvency

  • Based on the Altman-Z score of 1.31, we must say that STLAP is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.31, STLAP perfoms like the industry average, outperforming 48.39% of the companies in the same industry.
  • A Debt/Equity ratio of 0.38 indicates that STLAP is not too dependend on debt financing.
  • The Debt to Equity ratio of STLAP (0.38) is better than 77.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACCN/A
WACC6.61%
STLAP.PA Yearly LT Debt VS Equity VS FCFSTLAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B 80B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that STLAP should not have too much problems paying its short term obligations.
  • STLAP's Current ratio of 1.06 is on the low side compared to the rest of the industry. STLAP is outperformed by 67.74% of its industry peers.
  • STLAP has a Quick Ratio of 1.06. This is a bad value and indicates that STLAP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of STLAP (0.77) is worse than 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
STLAP.PA Yearly Current Assets VS Current LiabilitesSTLAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. STLAP.PA Growth Analysis

3.1 Past

  • The earnings per share for STLAP have decreased strongly by -16.56% in the last year.
  • STLAP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 31.54% yearly.
  • The Revenue has decreased by -2.15% in the past year.
  • The Revenue has been growing slightly by 2.93% on average over the past years.
EPS 1Y (TTM)-16.56%
EPS 3Y32%
EPS 5Y31.54%
EPS Q2Q%-13142.94%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y0.75%
Revenue growth 5Y2.93%
Sales Q2Q%8.07%

3.2 Future

  • Based on estimates for the next years, STLAP will show a decrease in Earnings Per Share. The EPS will decrease by -3.15% on average per year.
  • The Revenue is expected to grow by 7.56% on average over the next years.
EPS Next Y-62.6%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
EPS Next 5Y-3.15%
Revenue Next Year25.31%
Revenue Next 2Y17.08%
Revenue Next 3Y17.94%
Revenue Next 5Y7.56%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STLAP.PA Yearly Revenue VS EstimatesSTLAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B 200B
STLAP.PA Yearly EPS VS EstimatesSTLAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. STLAP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 2.33, the valuation of STLAP can be described as very cheap.
  • Based on the Price/Earnings ratio, STLAP is valued cheaply inside the industry as 93.55% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.64, STLAP is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 1.66, the valuation of STLAP can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, STLAP is valued cheaper than 96.77% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of STLAP to the average of the S&P500 Index (21.36), we can say STLAP is valued rather cheaply.
Industry RankSector Rank
PE 2.33
Fwd PE 1.66
STLAP.PA Price Earnings VS Forward Price EarningsSTLAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 64.52% of the companies in the same industry are more expensive than STLAP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.18
STLAP.PA Per share dataSTLAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • STLAP's earnings are expected to grow with 27.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.07
EPS Next 2Y18.5%
EPS Next 3Y27.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. STLAP.PA Dividend Analysis

5.1 Amount

  • STLAP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STLAP.PA Fundamentals: All Metrics, Ratios and Statistics

STELLANTIS NV

EPA:STLAP (4/30/2026, 7:00:00 PM)

6.215

-0.42 (-6.4%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Industry Strength14.86
Industry Growth46
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners48.42%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap18.05B
Revenue(TTM)153.51B
Net Income(TTM)-2.39B
Analysts69.44
Price Target10.87 (74.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.68
Dividend Growth(5Y)N/A
DP-81.93%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)28.67%
PT rev (3m)9.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.97%
EPS NY rev (3m)-45.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.75%
Valuation
Industry RankSector Rank
PE 2.33
Fwd PE 1.66
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.77
EV/EBITDA 5.18
EPS(TTM)2.67
EY42.96%
EPS(NY)3.75
Fwd EY60.33%
FCF(TTM)-5.52
FCFYN/A
OCF(TTM)-1.9
OCFYN/A
SpS50.32
BVpS25.18
TBVpS8.03
PEG (NY)N/A
PEG (5Y)0.07
Graham Number38.8937 (525.8%)
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)0.12%
ROA(5y)3.53%
ROE(3y)-4.1%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.41%
GM growth 5Y-43.81%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 5.91
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.31
F-Score1
WACC6.61%
ROIC/WACCN/A
Cap/Depr(3y)139.68%
Cap/Depr(5y)144.78%
Cap/Sales(3y)6.13%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.56%
EPS 3Y32%
EPS 5Y31.54%
EPS Q2Q%-13142.94%
EPS Next Y-62.6%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
EPS Next 5Y-3.15%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y0.75%
Revenue growth 5Y2.93%
Sales Q2Q%8.07%
Revenue Next Year25.31%
Revenue Next 2Y17.08%
Revenue Next 3Y17.94%
Revenue Next 5Y7.56%
EBIT growth 1Y-114.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1001.53%
EBIT Next 3Y150.48%
EBIT Next 5Y75.26%
FCF growth 1Y-767.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-139.82%
OCF growth 3YN/A
OCF growth 5YN/A

STELLANTIS NV / STLAP.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for STELLANTIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to STLAP.PA.


What is the valuation status for STLAP stock?

ChartMill assigns a valuation rating of 6 / 10 to STELLANTIS NV (STLAP.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for STELLANTIS NV?

STELLANTIS NV (STLAP.PA) has a profitability rating of 1 / 10.


How financially healthy is STELLANTIS NV?

The financial health rating of STELLANTIS NV (STLAP.PA) is 2 / 10.


What is the expected EPS growth for STELLANTIS NV (STLAP.PA) stock?

The Earnings per Share (EPS) of STELLANTIS NV (STLAP.PA) is expected to decline by -62.6% in the next year.